Skip to content

Clinical trials

Phase 3 Urinary Bladder, Overactive trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urinary Bladder, Overactive Phase: Phase 3 Country / region: Germany Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20042
20061
20072
20083
20093
20101
20121
20133
20141
20161

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Allergan5
Astellas Pharma Inc5
Pfizer3
Astellas Pharma Europe B.V.2
Astellas Pharma Europe Ltd.2
APOGEPHA Arzneimittel GmbH1
Ipsen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urinary Bladder, Overactive19
Urinary Incontinence11
Urologic Diseases3
Nocturia2
Urinary Bladder Diseases2
Urinary Incontinence, Urge2
Urinary Bladder, Neurogenic1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.